Sign in
4

Changes in Ownership

Pacira BioSciences, Inc. Filed Acc 0001628280-26-074524

Chief Medical Officer returned 216,729.67 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SLONIN JONATHAN Chief Medical Officer 2026-11-17 Returned to the company −216,729.67 $36.50 $7,910,633 0 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
SLONIN JONATHAN Chief Medical Officer 2026-11-17 Returned to the company · Stock Option (Right to Buy) −35,500 $52.37 2030-07-02 35,500 0 D: show line 2 in the form
SLONIN JONATHAN Chief Medical Officer 2026-11-17 Returned to the company · Stock Option (Right to Buy) −14,137 $60.96 2031-06-09 14,137 0 D: show line 3 in the form
SLONIN JONATHAN Chief Medical Officer 2026-11-17 Returned to the company · Stock Option (Right to Buy) −10,000 $60.79 2031-08-03 10,000 0 D: show line 4 in the form
SLONIN JONATHAN Chief Medical Officer 2026-11-17 Returned to the company · Stock Option (Right to Buy) −24,800 $59.39 2032-06-08 24,800 0 D: show line 5 in the form
SLONIN JONATHAN Chief Medical Officer 2026-11-17 Returned to the company · Stock Option (Right to Buy) −27,500 $38.74 2033-06-14 27,500 0 D: show line 6 in the form
SLONIN JONATHAN Chief Medical Officer 2026-11-17 Returned to the company · Stock Option (Right to Buy) −10,000 $32.07 2034-01-03 10,000 0 D: show line 7 in the form
Loading xslF345X06/wk-form4_1794951344.xml…